{"id":"tp-32113","type":"article-newspaper","title":"FDA Expands ANKTIVA Approval for BCG-Unresponsive Bladder Cancer","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/32113","datePublished":"2026-10-14T22:56:54.000Z","dateModified":"2026-10-14T22:56:54.000Z","language":"en","abstract":"The Oct. 14 decision adds adults with high-grade papillary-only tumors that have not spread into the bladder muscle to the drug’s approved use.","section":"Regulation","references":[]}